Loading…

Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2

Background—Interleukin 1 (IL-1) α and β are potent cytokines which play key roles in inflammation. They are controlled by IL-1 receptor antagonist (IL-1ra). Aims—To investigate the influence of mucosal inflammation and IL-1ra genotype on the IL-1ra:IL-1 balance. Patients and methods—IL-1α, IL-1β, an...

Full description

Saved in:
Bibliographic Details
Published in:Gut 1997-11, Vol.41 (5), p.651-657
Main Authors: Andus, T, Daig, R, Vogl, D, Aschenbrenner, E, Lock, G, Hollerbach, S, Köllinger, M, Schölmerich, J, Gross, V
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-b453t-41e4dc355af96d9272a34224a5868b3091fd0f0df9c48c636d97ff045dac8cd43
cites
container_end_page 657
container_issue 5
container_start_page 651
container_title Gut
container_volume 41
creator Andus, T
Daig, R
Vogl, D
Aschenbrenner, E
Lock, G
Hollerbach, S
Köllinger, M
Schölmerich, J
Gross, V
description Background—Interleukin 1 (IL-1) α and β are potent cytokines which play key roles in inflammation. They are controlled by IL-1 receptor antagonist (IL-1ra). Aims—To investigate the influence of mucosal inflammation and IL-1ra genotype on the IL-1ra:IL-1 balance. Patients and methods—IL-1α, IL-1β, and IL-1ra were measured by enzyme linked immunosorbent assay (ELISA) in biopsy specimens taken from inflamed and non-inflamed colon of 60 patients with Crohn’s disease (CD), 34 with ulcerative colitis (UC), 15 inflammatory controls, and 103 non-inflamed controls. IL-1ra genotype was determined by polymerase chain reaction and gel electrophoresis. Results—IL-1α and IL-1β were significantly increased in inflamed mucosa in inflammatory bowel disease (IBD) (CD: 53.5 (22.4) and 409.9 (118.7) pg/mg protein, respectively; UC: 18.9 (6.8) and 214.5 (78.2) pg/mg, respectively) and non-IBD patients (19.2 (7.4) and 281.4 (121.0) pg/mg, respectively; p
doi_str_mv 10.1136/gut.41.5.651
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1891562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4017420751</sourcerecordid><originalsourceid>FETCH-LOGICAL-b453t-41e4dc355af96d9272a34224a5868b3091fd0f0df9c48c636d97ff045dac8cd43</originalsourceid><addsrcrecordid>eNp9kc-uEyEUxidGc-29uvMBSDRxc6fC8GdgY2IarVcbjYkad4Qy0NI7AxUYtTsfwYVP6JPIdZomunAF4fud73DOV1UPEJwjhNmTzZjnBM3pnFF0q5ohwniNG85vVzMIUVvTloi71XlKOwgh5wKdVWeCICJaPKt-XA1r1SuvDQgW5K0BzmcTezNeOw8QSIeUzVAegQ598E6DYdQhqV_ff6qUgnYqu-DBV5e3fypTdl715Wp7NQyTqHz3j2s02uxziEBtimfKYGN8yIe9Ac296o5VfTL3j-dF9eHF8_eLl_Xq7fJq8WxVrwnFuSbIkE5jSpUVrBNN2yhMmoYoyhlfYyiQ7aCFnRWacM1wYVprIaGd0lx3BF9UTyff_bgeTKeNz1H1ch_doOJBBuXk34p3W7kJXyQqG6SsKQYPjwYxfB7L4HIXxliGTxK1rRAMsvamzeVE6RhSisaeOiAob-KTJT5JkKSyxFfwR0dTlbTqbSzJuHSqacoArIEFqyes7M58O8kqXkvW4pbKNx8X8vUn_u7VEq_ksvCPJ3497P7_gd_SbLoX</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1779960674</pqid></control><display><type>article</type><title>Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2</title><source>Open Access: PubMed Central</source><creator>Andus, T ; Daig, R ; Vogl, D ; Aschenbrenner, E ; Lock, G ; Hollerbach, S ; Köllinger, M ; Schölmerich, J ; Gross, V</creator><creatorcontrib>Andus, T ; Daig, R ; Vogl, D ; Aschenbrenner, E ; Lock, G ; Hollerbach, S ; Köllinger, M ; Schölmerich, J ; Gross, V</creatorcontrib><description><![CDATA[Background—Interleukin 1 (IL-1) α and β are potent cytokines which play key roles in inflammation. They are controlled by IL-1 receptor antagonist (IL-1ra). Aims—To investigate the influence of mucosal inflammation and IL-1ra genotype on the IL-1ra:IL-1 balance. Patients and methods—IL-1α, IL-1β, and IL-1ra were measured by enzyme linked immunosorbent assay (ELISA) in biopsy specimens taken from inflamed and non-inflamed colon of 60 patients with Crohn’s disease (CD), 34 with ulcerative colitis (UC), 15 inflammatory controls, and 103 non-inflamed controls. IL-1ra genotype was determined by polymerase chain reaction and gel electrophoresis. Results—IL-1α and IL-1β were significantly increased in inflamed mucosa in inflammatory bowel disease (IBD) (CD: 53.5 (22.4) and 409.9 (118.7) pg/mg protein, respectively; UC: 18.9 (6.8) and 214.5 (78.2) pg/mg, respectively) and non-IBD patients (19.2 (7.4) and 281.4 (121.0) pg/mg, respectively; p<0.0001) compared with normal controls (2.8 (0.6) and 30.6 (5.6) pg/mg, respectively). In CD IL-1α and β were also significantly increased in non-inflamed mucosa (6.1 (1.3) pg/mg and 88.7 (17.4) pg/mg, respectively; p<0.0012). IL-1ra:(IL-1α+β) ratios were significantly decreased in inflamed mucosa of patients with CD (182 (45); p<0.0001), UC (425 (136); p=0.0018) and without IBD (221 (76); p<0.0001), and in non-inflamed mucosa in CD (369 (149); p<0.0001) compared with normal controls (1307 (245); p<0.0001). Patients with IL-1ra genotype 2 had slightly but significantly reduced mucosal IL-1ra concentrations (p=0.003). The greatest difference was seen in colonic biopsy specimens from patients with inflamed Crohn’s disease. Conclusion—Mucosal inflammation can modulate the balance of the IL-1:IL-1ra system in colonic mucosa.]]></description><identifier>ISSN: 0017-5749</identifier><identifier>EISSN: 1468-3288</identifier><identifier>EISSN: 1458-3288</identifier><identifier>DOI: 10.1136/gut.41.5.651</identifier><identifier>PMID: 9414973</identifier><identifier>CODEN: GUTTAK</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and British Society of Gastroenterology</publisher><subject>Biological and medical sciences ; Biopsy ; Colon ; Crohn’s disease ; Cytokines ; Gastroenterology. Liver. Pancreas. Abdomen ; genotype ; Genotype &amp; phenotype ; Immune system ; Inflammation ; Inflammatory ; Inflammatory bowel disease ; interleukin 1 ; interleukin 1 receptor antagonist ; Medical sciences ; mucosal inflammation ; Other diseases. Semiology ; Proteins ; Rodents ; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus ; Studies ; Ulcers</subject><ispartof>Gut, 1997-11, Vol.41 (5), p.651-657</ispartof><rights>British Society of Gastroenterology</rights><rights>1998 INIST-CNRS</rights><rights>Copyright: 1997 British Society of Gastroenterology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b453t-41e4dc355af96d9272a34224a5868b3091fd0f0df9c48c636d97ff045dac8cd43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891562/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1891562/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2045620$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Andus, T</creatorcontrib><creatorcontrib>Daig, R</creatorcontrib><creatorcontrib>Vogl, D</creatorcontrib><creatorcontrib>Aschenbrenner, E</creatorcontrib><creatorcontrib>Lock, G</creatorcontrib><creatorcontrib>Hollerbach, S</creatorcontrib><creatorcontrib>Köllinger, M</creatorcontrib><creatorcontrib>Schölmerich, J</creatorcontrib><creatorcontrib>Gross, V</creatorcontrib><title>Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2</title><title>Gut</title><addtitle>Gut</addtitle><description><![CDATA[Background—Interleukin 1 (IL-1) α and β are potent cytokines which play key roles in inflammation. They are controlled by IL-1 receptor antagonist (IL-1ra). Aims—To investigate the influence of mucosal inflammation and IL-1ra genotype on the IL-1ra:IL-1 balance. Patients and methods—IL-1α, IL-1β, and IL-1ra were measured by enzyme linked immunosorbent assay (ELISA) in biopsy specimens taken from inflamed and non-inflamed colon of 60 patients with Crohn’s disease (CD), 34 with ulcerative colitis (UC), 15 inflammatory controls, and 103 non-inflamed controls. IL-1ra genotype was determined by polymerase chain reaction and gel electrophoresis. Results—IL-1α and IL-1β were significantly increased in inflamed mucosa in inflammatory bowel disease (IBD) (CD: 53.5 (22.4) and 409.9 (118.7) pg/mg protein, respectively; UC: 18.9 (6.8) and 214.5 (78.2) pg/mg, respectively) and non-IBD patients (19.2 (7.4) and 281.4 (121.0) pg/mg, respectively; p<0.0001) compared with normal controls (2.8 (0.6) and 30.6 (5.6) pg/mg, respectively). In CD IL-1α and β were also significantly increased in non-inflamed mucosa (6.1 (1.3) pg/mg and 88.7 (17.4) pg/mg, respectively; p<0.0012). IL-1ra:(IL-1α+β) ratios were significantly decreased in inflamed mucosa of patients with CD (182 (45); p<0.0001), UC (425 (136); p=0.0018) and without IBD (221 (76); p<0.0001), and in non-inflamed mucosa in CD (369 (149); p<0.0001) compared with normal controls (1307 (245); p<0.0001). Patients with IL-1ra genotype 2 had slightly but significantly reduced mucosal IL-1ra concentrations (p=0.003). The greatest difference was seen in colonic biopsy specimens from patients with inflamed Crohn’s disease. Conclusion—Mucosal inflammation can modulate the balance of the IL-1:IL-1ra system in colonic mucosa.]]></description><subject>Biological and medical sciences</subject><subject>Biopsy</subject><subject>Colon</subject><subject>Crohn’s disease</subject><subject>Cytokines</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>genotype</subject><subject>Genotype &amp; phenotype</subject><subject>Immune system</subject><subject>Inflammation</subject><subject>Inflammatory</subject><subject>Inflammatory bowel disease</subject><subject>interleukin 1</subject><subject>interleukin 1 receptor antagonist</subject><subject>Medical sciences</subject><subject>mucosal inflammation</subject><subject>Other diseases. Semiology</subject><subject>Proteins</subject><subject>Rodents</subject><subject>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</subject><subject>Studies</subject><subject>Ulcers</subject><issn>0017-5749</issn><issn>1468-3288</issn><issn>1458-3288</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp9kc-uEyEUxidGc-29uvMBSDRxc6fC8GdgY2IarVcbjYkad4Qy0NI7AxUYtTsfwYVP6JPIdZomunAF4fud73DOV1UPEJwjhNmTzZjnBM3pnFF0q5ohwniNG85vVzMIUVvTloi71XlKOwgh5wKdVWeCICJaPKt-XA1r1SuvDQgW5K0BzmcTezNeOw8QSIeUzVAegQ598E6DYdQhqV_ff6qUgnYqu-DBV5e3fypTdl715Wp7NQyTqHz3j2s02uxziEBtimfKYGN8yIe9Ac296o5VfTL3j-dF9eHF8_eLl_Xq7fJq8WxVrwnFuSbIkE5jSpUVrBNN2yhMmoYoyhlfYyiQ7aCFnRWacM1wYVprIaGd0lx3BF9UTyff_bgeTKeNz1H1ch_doOJBBuXk34p3W7kJXyQqG6SsKQYPjwYxfB7L4HIXxliGTxK1rRAMsvamzeVE6RhSisaeOiAob-KTJT5JkKSyxFfwR0dTlbTqbSzJuHSqacoArIEFqyes7M58O8kqXkvW4pbKNx8X8vUn_u7VEq_ksvCPJ3497P7_gd_SbLoX</recordid><startdate>19971101</startdate><enddate>19971101</enddate><creator>Andus, T</creator><creator>Daig, R</creator><creator>Vogl, D</creator><creator>Aschenbrenner, E</creator><creator>Lock, G</creator><creator>Hollerbach, S</creator><creator>Köllinger, M</creator><creator>Schölmerich, J</creator><creator>Gross, V</creator><general>BMJ Publishing Group Ltd and British Society of Gastroenterology</general><general>BMJ</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope></search><sort><creationdate>19971101</creationdate><title>Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2</title><author>Andus, T ; Daig, R ; Vogl, D ; Aschenbrenner, E ; Lock, G ; Hollerbach, S ; Köllinger, M ; Schölmerich, J ; Gross, V</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b453t-41e4dc355af96d9272a34224a5868b3091fd0f0df9c48c636d97ff045dac8cd43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Biological and medical sciences</topic><topic>Biopsy</topic><topic>Colon</topic><topic>Crohn’s disease</topic><topic>Cytokines</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>genotype</topic><topic>Genotype &amp; phenotype</topic><topic>Immune system</topic><topic>Inflammation</topic><topic>Inflammatory</topic><topic>Inflammatory bowel disease</topic><topic>interleukin 1</topic><topic>interleukin 1 receptor antagonist</topic><topic>Medical sciences</topic><topic>mucosal inflammation</topic><topic>Other diseases. Semiology</topic><topic>Proteins</topic><topic>Rodents</topic><topic>Stomach. Duodenum. Small intestine. Colon. Rectum. Anus</topic><topic>Studies</topic><topic>Ulcers</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Andus, T</creatorcontrib><creatorcontrib>Daig, R</creatorcontrib><creatorcontrib>Vogl, D</creatorcontrib><creatorcontrib>Aschenbrenner, E</creatorcontrib><creatorcontrib>Lock, G</creatorcontrib><creatorcontrib>Hollerbach, S</creatorcontrib><creatorcontrib>Köllinger, M</creatorcontrib><creatorcontrib>Schölmerich, J</creatorcontrib><creatorcontrib>Gross, V</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Gut</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Andus, T</au><au>Daig, R</au><au>Vogl, D</au><au>Aschenbrenner, E</au><au>Lock, G</au><au>Hollerbach, S</au><au>Köllinger, M</au><au>Schölmerich, J</au><au>Gross, V</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2</atitle><jtitle>Gut</jtitle><addtitle>Gut</addtitle><date>1997-11-01</date><risdate>1997</risdate><volume>41</volume><issue>5</issue><spage>651</spage><epage>657</epage><pages>651-657</pages><issn>0017-5749</issn><eissn>1468-3288</eissn><eissn>1458-3288</eissn><coden>GUTTAK</coden><abstract><![CDATA[Background—Interleukin 1 (IL-1) α and β are potent cytokines which play key roles in inflammation. They are controlled by IL-1 receptor antagonist (IL-1ra). Aims—To investigate the influence of mucosal inflammation and IL-1ra genotype on the IL-1ra:IL-1 balance. Patients and methods—IL-1α, IL-1β, and IL-1ra were measured by enzyme linked immunosorbent assay (ELISA) in biopsy specimens taken from inflamed and non-inflamed colon of 60 patients with Crohn’s disease (CD), 34 with ulcerative colitis (UC), 15 inflammatory controls, and 103 non-inflamed controls. IL-1ra genotype was determined by polymerase chain reaction and gel electrophoresis. Results—IL-1α and IL-1β were significantly increased in inflamed mucosa in inflammatory bowel disease (IBD) (CD: 53.5 (22.4) and 409.9 (118.7) pg/mg protein, respectively; UC: 18.9 (6.8) and 214.5 (78.2) pg/mg, respectively) and non-IBD patients (19.2 (7.4) and 281.4 (121.0) pg/mg, respectively; p<0.0001) compared with normal controls (2.8 (0.6) and 30.6 (5.6) pg/mg, respectively). In CD IL-1α and β were also significantly increased in non-inflamed mucosa (6.1 (1.3) pg/mg and 88.7 (17.4) pg/mg, respectively; p<0.0012). IL-1ra:(IL-1α+β) ratios were significantly decreased in inflamed mucosa of patients with CD (182 (45); p<0.0001), UC (425 (136); p=0.0018) and without IBD (221 (76); p<0.0001), and in non-inflamed mucosa in CD (369 (149); p<0.0001) compared with normal controls (1307 (245); p<0.0001). Patients with IL-1ra genotype 2 had slightly but significantly reduced mucosal IL-1ra concentrations (p=0.003). The greatest difference was seen in colonic biopsy specimens from patients with inflamed Crohn’s disease. Conclusion—Mucosal inflammation can modulate the balance of the IL-1:IL-1ra system in colonic mucosa.]]></abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and British Society of Gastroenterology</pub><pmid>9414973</pmid><doi>10.1136/gut.41.5.651</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0017-5749
ispartof Gut, 1997-11, Vol.41 (5), p.651-657
issn 0017-5749
1468-3288
1458-3288
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1891562
source Open Access: PubMed Central
subjects Biological and medical sciences
Biopsy
Colon
Crohn’s disease
Cytokines
Gastroenterology. Liver. Pancreas. Abdomen
genotype
Genotype & phenotype
Immune system
Inflammation
Inflammatory
Inflammatory bowel disease
interleukin 1
interleukin 1 receptor antagonist
Medical sciences
mucosal inflammation
Other diseases. Semiology
Proteins
Rodents
Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
Studies
Ulcers
title Imbalance of the interleukin 1 system in colonic mucosa—association with intestinal inflammation and interleukin 1 receptor agonist genotype 2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T11%3A15%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Imbalance%20of%20the%20interleukin%201%20system%20in%20colonic%20mucosa%E2%80%94association%20with%20intestinal%20inflammation%20and%20interleukin%201%20receptor%20agonist%20genotype%202&rft.jtitle=Gut&rft.au=Andus,%20T&rft.date=1997-11-01&rft.volume=41&rft.issue=5&rft.spage=651&rft.epage=657&rft.pages=651-657&rft.issn=0017-5749&rft.eissn=1468-3288&rft.coden=GUTTAK&rft_id=info:doi/10.1136/gut.41.5.651&rft_dat=%3Cproquest_pubme%3E4017420751%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b453t-41e4dc355af96d9272a34224a5868b3091fd0f0df9c48c636d97ff045dac8cd43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1779960674&rft_id=info:pmid/9414973&rfr_iscdi=true